СМИ

-Yvar Verhoeven meets students after his presentation at John's Hopkins, November 13th, 2009. -The first patient to be treated with Dr. Ko's 3BP compound. -A Translational Study "Case Report" on the Small Molecule "Energy Blocker" 3-Bromopyruvate (3BP) as a Potent

Семинар группы по интересам митохондрий NCI и NIH: Педерсен Джонса Хопкинса обращается к роли митохондрий в раке https://videocast.nih.gov/summary.asp?live=7542&bhcp=1